Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement?
- PMID: 15920487
- DOI: 10.1038/sj.leu.2403818
Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement?
Abstract
We determined bone marrow karyotype at diagnosis in four female acute myeloid leukemia (AML) or myelodysplasia patients, aged between 52 and 56 years. In each case, we observed chromosome rearrangement involving the same 4q24 band. Three patients had a balanced reciprocal translocation as the sole abnormality - t(3;4)(q26;q24), t(4;5)(q24;p16) and t(4;7)(q24;q21) - and the fourth had del(4)(q23q24), +4. We used a set of 4q BAC probes for fluorescent in situ hybridization (FISH) in these four cases. We found a 4q24 submicroscopic deletion in all three translocations, with a common deletion of approximately 0.5 Mb. In three cases, we concluded that rearrangement occurred in an early hematopoietic stem cell, as it was detected, in mosaic with a normal karyotype, in a fraction of remission bone marrow cells, peripheral T and B lymphocytes, malignant lymph node T-lymphoma cells in one case and B-lymphoblastoid cell lines established in two cases. Moreover, one of 10 additional AML patients tested by FISH had a normal karyotype and deletion of one of the commonly deleted probe sequences. A tumor suppressor gene may therefore be involved, especially as two patients developed malignant lymphoma at the same time as myeloid proliferation.
Leukemia (2005) 19, 1411-1415.
Similar articles
-
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.Leukemia. 2002 Sep;16(9):1745-51. doi: 10.1038/sj.leu.2402605. Leukemia. 2002. PMID: 12200689
-
Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.Leukemia. 1996 Apr;10(4):662-8. Leukemia. 1996. PMID: 8618444
-
Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.Cancer Genet Cytogenet. 2006 Apr 1;166(1):82-5. doi: 10.1016/j.cancergencyto.2005.10.007. Cancer Genet Cytogenet. 2006. PMID: 16616115
-
Deletions of chromosome 5 in malignant myeloid disorders.Cancer Surv. 1992;15:143-59. Cancer Surv. 1992. PMID: 1451109 Review.
-
Myeloid neoplasm with t(3;8)(q26;q24): report of six cases and review of the literature.Leuk Lymphoma. 2014 Nov;55(11):2532-7. doi: 10.3109/10428194.2013.878460. Epub 2014 Feb 24. Leuk Lymphoma. 2014. PMID: 24397594 Review.
Cited by
-
Heterogeneity of molecular markers in chronic myelomonocytic leukemia: a disease associated with several gene alterations.Cell Mol Life Sci. 2012 Sep;69(17):2853-61. doi: 10.1007/s00018-012-0956-y. Epub 2012 Mar 14. Cell Mol Life Sci. 2012. PMID: 22415325 Free PMC article. Review.
-
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders.Front Oncol. 2016 Aug 22;6:187. doi: 10.3389/fonc.2016.00187. eCollection 2016. Front Oncol. 2016. PMID: 27597933 Free PMC article. Review.
-
Epigenetics of neurological cancers.Future Oncol. 2009 Dec;5(10):1615-29. doi: 10.2217/fon.09.132. Future Oncol. 2009. PMID: 20001799 Free PMC article. Review.
-
5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells.Genome Biol. 2011 Jun 20;12(6):R54. doi: 10.1186/gb-2011-12-6-r54. Genome Biol. 2011. PMID: 21689397 Free PMC article.
-
TET2 Promoter DNA Methylation and Expression Analysis in Pediatric B-cell Acute Lymphoblastic Leukemia.Hematol Rep. 2014 Mar 28;6(1):5333. doi: 10.4081/hr.2014.5333. eCollection 2014 Jan 29. Hematol Rep. 2014. PMID: 24711921 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous